Scale | Jamaica | Kenya | Uganda | South Africa | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pre (int. vs. con.) | Intervention | Control | Pre (int. vs con.) | Intervention | Control | Pre (int. vs con.) | Intervention | Control | Intervention | |||||||||
Pre | Post | Pre | Post | Pre | Post | Pre | Post | Pre | Post | Pre | Post | Pre | Post | |||||
Total | 216 | 121 | 93 | 95 | 104 | 217 | 100 | 161 | 117 | 115 | 276 | 135 | 103 | 141 | 117 | 157 | 120 | |
Clinical practices—self | Number | 205 | 115 | 89 | 90 | 97 | 206 | 97 | 160 | 109 | 113 | 270 | 135 | 99 | 135 | 117 | 155 | 117 |
Missing | 11 | 6 | 4 | 5 | 7 | 11 | 3 | 1 | 8 | 2 | 6 | 0 | 4 | 6 | 0 | 2 | 3 | |
μ(SD) | 0.46 (0.26) | 0.44 (0.24) | 0.42 (0.25) | 0.50 (0.28) | 0.47 (0.25) | 0.71 (0.24) | 0.70 (0.25) | 0.76 (0.25) | 0.71 (0.24) | 0.73 (0.24) | 0.56 (0.24) | 0.59 (0.24) | 0.64 (0.28) | 0.53 (0.24) | 0.56 (0.28) | 0.67 (0.29) | 0.78 (0.24) | |
95 % CI | 0.43–0.50 | 0.40–0.48 | 0.37–0.48 | 0.44–0.56 | 0.42–0.52 | 0.67–0.74 | 0.65–0.75 | 0.72–0.80 | 0.67–0.76 | 0.69–0.77 | 0.53–0.58 | 0.55–0.63 | 0.58–0.69 | 0.48–0.57 | 0.51–0.61 | 0.62–0.72 | 0.73–0.82 | |
p valuea | 0.121 | 0.8831 | 0.809 | 0.3988 | 0.038 | 0.7663 | 0.002 | |||||||||||
Clinical practices—peers | Number | 197 | 112 | 83 | 85 | 95 | 209 | 98 | 156 | 111 | 111 | 273 | 135 | 99 | 138 | 117 | 153 | 117 |
Missing | 19 | 9 | 10 | 10 | 9 | 8 | 2 | 5 | 6 | 4 | 3 | 0 | 4 | 3 | 0 | 4 | 3 | |
μ(SD) | 0.54 (0.29) | 0.51 (0.29) | 0.48 (0.28) | 0.58 (0.28) | 0.53 (0.30) | 0.73 (0.25) | 0.76 (0.24) | 0.81 (0.25) | 0.71 (0.25) | 0.76 (0.25) | 0.60 (0.24) | 0.63 (0.24) | 0.63 (0.30) | 0.57 (0.24) | 0.65 (0.29) | 0.72 (0.30) | 0.79 (0.27) | |
95 % CI | 0.50–0.58 | 0.46–0.57 | 0.42–0.54 | 0.52–0.65 | 0.45–0.58 | 0.70–0.77 | 0.71–0.81 | 0.77–0.85 | 0.67–0.76 | 0.71–0.81 | 0.57–0.63 | 0.59–0.67 | 0.57–0.69 | 0.53–0.61 | 0.59–0.70 | 0.68–0.77 | 0.74–0.83 | |
p valuea | 0.086 | 0.5527 | 0.229 | 0.7896 | 0.036 | 0.1199 | 0.098 | |||||||||||
Quality assurance | Number | 210 | 116 | 92 | 94 | 101 | 210 | 99 | 161 | 111 | 113 | 268 | 133 | 102 | 135 | 116 | 154 | 118 |
Missing | 6 | 5 | 1 | 1 | 3 | 7 | 1 | 0 | 6 | 2 | 8 | 2 | 1 | 6 | 1 | 3 | 2 | |
μ(SD) | 0.71 (0.28) | 0.67 (0.29) | 0.69 (0.30) | 0.76 (0.25) | 0.67 (0.30) | 0.72 (0.30) | 0.77 (0.29) | 0.82 (0.21) | 0.67 (0.31) | 0.81 (0.24) | 0.49 (0.29) | 0.52 (0.31) | 0.56 (0.30) | 0.45 (0.27) | 0.74 (0.26) | 0.72 (0.31) | 0.84 (0.22) | |
95 % CI | 0.67–0.75 | 0.61–0.72 | 0.63–0.75 | 0.70–0.80 | 0.61–0.73 | 0.68–0.76 | 0.72–0.83 | 0.78–0.85 | 0.62–0.73 | 0.77–0.86 | 0.45–0.52 | 0.47–0.57 | 0.50–0.62 | 0.41–0.50 | 0.70–0.79 | 0.67–0.77 | 0.80–0.88 | |
p valuea | 0.023 | 0.0262 | 0.016 | 0.0401 | 0.069 | 0.0001 | 0.001 | |||||||||||
Workplace policies | Number | 208 | 115 | 92 | 93 | 98 | 210 | 100 | 159 | 110 | 114 | 271 | 133 | 101 | 138 | 115 | 153 | 119 |
Missing | 8 | 6 | 1 | 2 | 6 | 7 | 0 | 2 | 7 | 1 | 5 | 2 | 2 | 3 | 2 | 4 | 1 | |
μ(SD) | 0.80 (20) | 0.78 (0.22) | 0.81 (0.21) | 0.84 (0.19) | 0.77 (0.21) | 0.85 (0.20) | 0.89 (0.16) | 0.86 (0.17) | 0.82 (0.27) | 0.87 (0.18) | 0.56 (0.32) | 0.65 (0.32) | 0.62 (0.31) | 0.47 (0.31) | 0.76 (0.26) | 0.82 (0.22) | 0.87 (0.17) | |
95 % CI | 0.78–0.83 | 0.74–0.82 | 0.77–0.85 | 0.80–0.88 | 0.73–0.81 | 0.82–0.88 | 0.86–0.93 | 0.83–0.88 | 0.77–0.86 | 0.84–0.91 | 0.52–0.59 | 0.59–0.70 | 0.56–0.68 | 0.42–0.52 | 0.71–0.81 | 0.79–0.85 | 0.84–0.90 | |
p valuea | 0.025 | 0.0121 | 0.006 | 0.540 | 0.000 | 0.0001 | 0.031 |